SCI:NYSEService Corporation International Analysis
Data as of 2026-05-27 - not real-time
$77.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Service Corporation International trades around $77, just below its 20‑day SMA of 78.5 and near the identified support level of $75.5, suggesting limited downside cushion. The RSI of 39 points to a mildly oversold condition, yet the MACD histogram remains in bearish territory, indicating continued short‑term pressure. The latest quarter missed consensus EPS expectations, posting $0.97 versus the forecast $1.01, and funeral segment revenue slipped 2.9%, adding to the near‑term uncertainty. On the fundamentals side, the company delivers a robust ROE of 33% and a healthy operating margin of 22%, supported by strong cash flow generation and a dividend yield of 1.88% with a modest payout ratio of 35%, underscoring dividend sustainability. However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio exceeding 300%, which could constrain future flexibility. Valuation metrics such as a forward P/E of ~17 and a price‑to‑book of 6.5 suggest the stock is priced above intrinsic benchmarks, rendering it overvalued at current levels. Demographic tailwinds and a diversified service portfolio provide a solid long‑term backdrop, but the combination of high leverage and recent earnings disappointment tempers enthusiasm in the near term.
Investors should weigh the attractive dividend and strong cash generation against the elevated valuation and bearish technical signals. The low beta and modest 30‑day volatility imply limited market‑wide shocks, but sector cyclicality and regulatory scrutiny remain medium‑level risks. A cautious stance—holding the position while monitoring earnings trends and any deleveraging actions—appears prudent, with a potential shift to buying if the stock can correct towards its fair value and demonstrate improved earnings momentum.
Investors should weigh the attractive dividend and strong cash generation against the elevated valuation and bearish technical signals. The low beta and modest 30‑day volatility imply limited market‑wide shocks, but sector cyclicality and regulatory scrutiny remain medium‑level risks. A cautious stance—holding the position while monitoring earnings trends and any deleveraging actions—appears prudent, with a potential shift to buying if the stock can correct towards its fair value and demonstrate improved earnings momentum.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent EPS miss and bearish MACD
- Proximity to technical support level
- Oversold RSI indicating limited further downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong ROE and sustainable dividend
- Demographic tailwinds supporting funeral demand
- Potential valuation correction toward fair value
Long Term
> 3 yearsNeutral
Model confidence: 8/10
Key Factors
- Stable cash flow and dividend growth
- High leverage requiring monitoring
- Long‑term industry resilience despite cyclical pressures
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin12.36%
P/E Ratio20.3
ROE33.11%
ROA3.40%
Debt/Equity325.74
P/B Ratio6.6
Op. Cash Flow$965.4M
Free Cash Flow$369.4M
Technical Analysis
TrendNeutral
RSI39.5
Support$75.52
Resistance$86.92
MA 20$78.53
MA 50$80.59
MA 200$80.48
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$2.99
Target Price$96.33
Upside/Downside25.11%
GradeOvervalued
TypeBlend
Dividend Yield1.88%
Risk Assessment
Beta0.10
Volatility26.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.